Intelgenx Technologies Stock Price, News & Analysis (CVE:IGX)

C$0.95 -0.01 (-1.04 %)
(As of 01/19/2018 04:00 PM ET)
Previous CloseC$0.95
Today's RangeC$0.95 - C$0.96
52-Week RangeC$0.78 - C$1.39
Volume12,900 shs
Average Volume14,414 shs
Market CapitalizationC$62.98 million
P/E Ratio-31.67
Dividend YieldN/A
Beta-0.04

About Intelgenx Technologies (CVE:IGX)

IntelGenx Technologies Corp., a drug delivery company, develops novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers RIZAPORT, an oral thin film formulation of rizatriptan benzoate for the treatment of acute migraines. The company’s products under development comprise INT0001/2004, an anti-hypertension drug; INT0004/2006, an antidepressant; INT0007/2006 for the treatment of erectile dysfunction; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid dependence; INT0036/2012 for schizophrenia; and INT0043/2015 to treat mild cognitive impairment and Alzheimer’s disease. It is also developing various products, including INT0037/2013, INT0039/2013, INT0040/2014, INT0041/2015, INT0042/2015, and INT0044/2016 based on three delivery platform technologies, which consist of VersaFilm, an oral film technology; VersaTab, a multilayer tablet technology; and AdVersa, a mucoadhesive tablet technology. The company has co-development and commercialization agreements with RedHill Biopharma Ltd.; Par Pharmaceutical Companies, Inc.; and Endo Ventures Ltd., as well as a licensing, development, and supply agreement with Chemo Group. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Saint-Laurent, Canada.

Receive IGX News and Ratings via Email

Sign-up to receive the latest news and ratings for IGX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorHealthcare
SymbolCVE:IGX
CUSIPN/A
PhoneN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-31.6666666666667
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares66,931,000

Intelgenx Technologies (CVE:IGX) Frequently Asked Questions

What is Intelgenx Technologies' stock symbol?

Intelgenx Technologies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "IGX."

How were Intelgenx Technologies' earnings last quarter?

Intelgenx Technologies Corp. (CVE:IGX) released its quarterly earnings data on Thursday, November, 9th. The company reported ($0.01) earnings per share for the quarter, meeting the consensus estimate of ($0.01). View Intelgenx Technologies' Earnings History.

When will Intelgenx Technologies make its next earnings announcement?

Intelgenx Technologies is scheduled to release their next quarterly earnings announcement on Tuesday, March, 27th 2018. View Earnings Estimates for Intelgenx Technologies.

Who are some of Intelgenx Technologies' key competitors?

How do I buy Intelgenx Technologies stock?

Shares of Intelgenx Technologies and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Intelgenx Technologies' stock price today?

One share of Intelgenx Technologies stock can currently be purchased for approximately C$0.95.

How big of a company is Intelgenx Technologies?

Intelgenx Technologies has a market capitalization of C$62.98 million.


MarketBeat Community Rating for Intelgenx Technologies (IGX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  7 (Vote Outperform)
Underperform Votes:  6 (Vote Underperform)
Total Votes:  13
MarketBeat's community ratings are surveys of what our community members think about Intelgenx Technologies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Intelgenx Technologies (CVE:IGX) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Intelgenx Technologies (CVE:IGX) Earnings History and Estimates Chart

Earnings by Quarter for Intelgenx Technologies (CVE:IGX)

Intelgenx Technologies (CVE IGX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/27/2018        
11/9/2017Q3 2017C($0.01)C($0.01)ViewN/AView Earnings Details
8/10/2017Q2 2017C($0.01)C($0.01)ViewN/AView Earnings Details
5/11/2017Q1 2017C($0.01)ViewN/AView Earnings Details
8/11/2016Q2 2016C($0.02)ViewN/AView Earnings Details
5/10/2016Q1 2016C($0.02)ViewN/AView Earnings Details
3/30/2016Q4 2015C$0.01ViewN/AView Earnings Details
11/3/2015Q3 2015C$0.03ViewN/AView Earnings Details
11/12/2014Q3 2014C($0.01)ViewN/AView Earnings Details
8/7/2014Q2 2014C($0.01)ViewN/AView Earnings Details
5/13/2014Q1 2014C($0.01)ViewN/AView Earnings Details
3/11/2014Q4 2013C($0.01)ViewN/AView Earnings Details
11/8/2013Q3 2013C($0.01)ViewN/AView Earnings Details
5/14/2013Q1 2013C($0.01)ViewN/AView Earnings Details
3/18/2013Q4 2012C($0.01)ViewN/AView Earnings Details
11/13/2012Q3 2012C($0.01)ViewN/AView Earnings Details
8/7/2012Q2 2012C($0.01)ViewN/AView Earnings Details
5/15/2012Q1 2012C($0.01)ViewN/AView Earnings Details
3/29/2012Q4 2011C($0.01)ViewN/AView Earnings Details
11/9/2011Q3 2011C($0.01)ViewN/AView Earnings Details
8/9/2011Q2 2011C($0.01)ViewN/AView Earnings Details
5/11/2011Q1 2011C($0.01)ViewN/AView Earnings Details
3/30/2011Q4 2010C($0.02)ViewN/AView Earnings Details
8/12/2010Q2 2010C($0.03)ViewN/AView Earnings Details
5/14/2010Q1 2010C($0.02)ViewN/AView Earnings Details
3/31/2010Q4 2009C($0.01)ViewN/AView Earnings Details
11/10/2009Q3 2009C($0.03)ViewN/AView Earnings Details
5/13/2009Q1 2009C($0.04)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Intelgenx Technologies (CVE:IGX) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Intelgenx Technologies (CVE:IGX)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Intelgenx Technologies (CVE IGX)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Intelgenx Technologies (CVE IGX) News Headlines

Source:
DateHeadline
IntelGenx Submits Montelukast VersaFilm Clinical Trial Application With Health CanadaIntelGenx Submits Montelukast VersaFilm Clinical Trial Application With Health Canada
www.finanznachrichten.de - November 11 at 11:41 AM
Intelgenx Technologies Corp. (IGX) to Release Earnings on ThursdayIntelgenx Technologies Corp. (IGX) to Release Earnings on Thursday
www.americanbankingnews.com - November 3 at 10:58 AM
IntelGenX Technologies Corp. (IGX) Scheduled to Post Earnings on ThursdayIntelGenX Technologies Corp. (IGX) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - August 4 at 3:32 PM

SEC Filings

Intelgenx Technologies (CVE:IGX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Intelgenx Technologies (CVE IGX) Stock Chart for Saturday, January, 20, 2018

Loading chart…

This page was last updated on 1/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.